Your browser doesn't support javascript.
loading
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.
Shibuya, Kendall C; Goel, Vikas K; Xiong, Wei; Sham, Jonathan G; Pollack, Seth M; Leahy, Allison M; Whiting, Samuel H; Yeh, Matthew M; Yee, Cassian; Riddell, Stanley R; Pillarisetty, Venu G.
Afiliação
  • Shibuya KC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Goel VK; Department of Surgery, University of Washington, Seattle, Washington, United States of America.
  • Xiong W; Department of Pathology, University of Washington, Seattle, Washington, United States of America; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Sham JG; Department of Surgery, University of Washington, Seattle, Washington, United States of America.
  • Pollack SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Leahy AM; Surgical Oncology, Seattle Cancer Care Alliance, Seattle, Washington, United States of America.
  • Whiting SH; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Yeh MM; Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington, Seattle, Washington, United States of America.
  • Yee C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Pillarisetty VG; Department of Surgery, University of Washington, Seattle, Washington, United States of America.
PLoS One ; 9(5): e96565, 2014.
Article em En | MEDLINE | ID: mdl-24794217
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pâncreas / Adenocarcinoma / Terapia Neoadjuvante / Carcinoma Ductal Pancreático / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pâncreas / Adenocarcinoma / Terapia Neoadjuvante / Carcinoma Ductal Pancreático / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos